INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 23,958 Value ($000) $66 Avg Close Range
Q3 2024
Shares 27,949 Value ($000) $146 Avg Close Range
Q2 2024
Shares 27,949 Value ($000) $125 Avg Close Range
Q1 2024
Shares 19,206 Value ($000) $147 Avg Close Range
Q4 2023
Shares 26,507 Value ($000) $113 Avg Close Range
Q3 2023
Shares 18,035 Value ($000) $76 Avg Close Range
Q2 2023
Shares 18,035 Value ($000) $100 Avg Close Range